Merck inks multi-million dollar deal with Cognizant

By Kirsty Barnes

- Last updated on GMT

Related tags: Outsourcing

Merck & Co. has just inked "multi-million dollar" deal
with Cognizant, at a time when the US-based IT services firm is
pursuing a greater presence in the life sciences sector.

The firms have already been working together for the past two years to streamline and consolidate Merck's IT operations and according to Rich Branton, vice president of Global Technology Solutions at Merck, this was a large factor in the decision to award the new contract to Cognizant Under the arrangement, Cognizant said it will see its role with Merck now extended to that of a "key technology partner providing a full suite of services encompassing applications outsourcing, IT infrastructure management and business process outsourcing services".​ Cognizant has demonstrated a particular affinity for the life sciences market of late - in October it dished out $135m on its first acquisition and this was to buy a fellow US firm with a specialty in this field. The purchase of MarketrX, due to close this quarter, was executed primarily so that it could extend its "existing portfolio to the life sciences space",​ Cognizant said at the time. MarketrX provides analytics, market research, and software services and counts the 20 largest pharmaceutical companies and four of the five top biotechnology firms as its clients. Both companies operate largely around offshore delivery models in low-cost destinations, particularly India, where Cognizant has seven delivery centres, so as to remain cost-competitive in the North American and European markets.

Related news

Related products

show more

GLP Tissue Cross Reactivity Testing

GLP Tissue Cross Reactivity Testing

Precision for Medicine | 11-Oct-2021 | Product Brochure

Precision for Medicine's unique combination of research services and tissue procurement capabilities form the pillars of our GLP Tissue Cross Reactivity...

Automating clinical trials for success

Automating clinical trials for success

Formedix | 06-Oct-2021 | Technical / White Paper

This article gives gives a brief overview of why automation is absolutely essential for clinical trial success.

Related suppliers

Follow us

Products

View more

Webinars